Clinical Pharmacology Considerations for Novel Therapeutic Modalities

(1:57:53)

Overview of Novel Therapeutic Approaches to IBD

(5:3)

Novel Therapeutic Approach: Breaking the Wall of Ineffective Cancer Therapies | Ana Montalban Arques

(3:20)

Novel therapeutic strategies in ALL

(57)

Novel therapeutic agents in the treatment of Hodgkin and non-Hodgkin Lymphoma

(2:3)

Optimal Management of HCC: Integrating Novel Therapeutic Approaches Across the Continuum of Care

(1:29:6)

Novel therapeutic approaches

(48:20)

Investigating how Tpz-1 may be used as a novel therapeutic agent

(24:35)

Post #ASH24 Webinar Dedicated to AML

(54:16)

Novel Therapeutic Approaches in CLL

(23:41)

Novel therapeutic approaches in B-progenitor ALL

(5:47)

Developing novel therapeutic strategies to target DNA damage response

(3:36)

Novel therapeutic options for PD-1 refractory melanoma

(44)

SIOP 2024: EDUCATIONAL: NOVEL THERAPEUTIC APPROACHES TO HIGH RISK B-ALL

(1:37:58)

Investigating the proteasome stress response as a potential novel therapeutic target in myeloma

(1:48)

IDEF Educational Series Webinar Fireside Chat on Novel Therapeutic Approaches for the Management of

(1:3:6)

Intra-tumoral hypoxia and the development of novel therapeutic strategies for PABC

(59)

Oxford Cancer Theme Video - Novel Therapeutics

(2:6)

Pre-MDS states: novel therapeutic approaches, and determining appropriate trial endpoints

(3:17)

Novel Therapeutic Approaches In ALL

(4:5)